The mission of the IMWG is to conduct collaborative basic, clinical, and translational research to improve outcomes for myeloma patients while providing scientifically validated, critically appraised consensus guidelines for the myeloma community globally.
International Myeloma Working Group (IMWG): Advancing Myeloma Research Through Global Collaboration
Captured at the 15th Annual IMWG Summit
This video offers a glimpse into the International Myeloma Foundation's International Myeloma Working Group (IMWG), a collaboration of leading myeloma researchers and clinicians from around the world.
The IMWG plays a critical role in:
- Conducting collaborative research projects across various scientific fields to accelerate advancements in myeloma treatment.
- Developing and publishing evidence-based guidelines for the global Myeloma community.
- Serving as a platform for top researchers to discuss key gaps, brainstorm ideas, and drive continuous improvement in Myeloma patient outcomes.
This annual summit exemplifies the power of collaboration in tackling Myeloma.
Previous Post
Can stored and harvested stem cells be used after CAR T-cell therapy?
Next Post
DREAMM-7: Belamaf+BVd vs DVd in RRMM, subgroup analyses of phase 3 trial comparing regimens after relapse




